Lobbying

Orchard Laboratories's latest lobbying report covers Q4 2024, at $20K. Its first report covers Q3 2023; the issues it reports most are Medical/Disease Research/Clinical Labs.

Orchard Laboratories

Latest quarter
No record
Q2 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q2 2026 against the quarter before
First report
Q3 2023
The first quarter a report named it

Lobbying by quarter

Orchard Laboratories lobbying by quarter
Orchard Laboratories lobbying by quarter
QuarterAmountReports
Q3 2023$01
Q4 2023$30K1
Q1 2024$30K1
Q2 2024$30K1
Q3 2024$30K1
Q4 2024$20K1
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00

Policy issues the reports name

  • Medical research and clinical labs3 reports

A report that names several issues counts once for each.

Who was lobbied

  • HOUSE OF REPRESENTATIVES3 reports
  • SENATE3 reports

Firms it paid

Firm
Troutman Strategies$140K6 quarters

Former officials lobbying for it

Former position
CHRISTOPHER BAXTERResearch Assistant, Senator Bob MenendezQ2 2024
LINDSAY JORDAN AUSTINLegislative Assistant, Rep. Lynn WestmorelandQ2 2024
RYAN DIFFLEYLegislative Assistant, Rep. Robert AderholtQ2 2024
TOM TILTONLegislative Assistant, Rep. Betty SuttonQ2 2024

Lobbying reports

Filed by
25/01/21for Q4 2024Troutman Strategies$20K
24/10/17for Q3 2024Troutman Strategies$30K
24/07/19for Q2 2024Troutman Strategies$30K
24/04/19for Q1 2024Troutman Strategies$30K
24/01/18for Q4 2023Troutman Strategies$30K
23/10/23for Q3 2023Troutman StrategiesUnder $5,000
23/10/10for Q3 2023Troutman StrategiesUnder $5,000